Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

ASCELIA Aktie

>ASCELIA Performance
1 Woche: 0%
1 Monat: +2,3%
3 Monate: +69,0%
6 Monate: +71,4%
1 Jahr: -51,6%
laufendes Jahr: +71,4%
>ASCELIA Aktie
Name:  ASCELIA PHARMA AB
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0010573113 / A2H81X
Symbol/ Ticker:  7ZA (Frankfurt)
Kürzel:  FRA:7ZA, ETR:7ZA, 7ZA:GR
Index:  -
Webseite:  https://www.ascelia.com/
Marktkapitalisierung:  38.73 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / 6.05 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ASCELIA
Letzte Datenerhebung:  04.07.25
>ASCELIA Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
Leerverk. Aktien: -
>ASCELIA Peer Group

 
16.05.25 - 07:54
 Ascelia Pharma: Quarterly Report Q1 2025: Positive Outcome of Orviglance FDA Meeting in Advance of the NDA Submission (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / May 16, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker: ACE) today published its Interim Report Q1 for 2025 (January - March), which is now availab......
07.05.25 - 16:54
 Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025 (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / May 7, 2025 / Ascelia Pharma (STO:ACE) - Today, on 7 May 2025, an annual general meeting was held in Ascelia Pharma AB. A summary of the adopted resolutions follows be......
30.04.25 - 12:06
 Change in Number of Shares and Votes in Ascelia Pharma AB (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / April 30, 2025 / Ascelia Pharma (STO:ACE)During April, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the exerc......
11.04.25 - 14:18
 Ascelia Pharma: Annual Report 2024: Orviglance Advances to Registration Phase after Successful Phase 3 Study Completion (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / April 11, 2025 / Ascelia Pharma (STO:ACE):The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translat......
08.04.25 - 22:30
 Ascelia Pharma Announces Publication of Orviglance Study in Investigative Radiology (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / April 8, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions,......
04.04.25 - 14:06
 Notice of Annual General Meeting in Ascelia Pharma AB (Accesswire)
 
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / April......
04.04.25 - 08:06
 Ascelia Pharma Announces Acceptance of Study on Burden of Illness Real-World Data of Orviglance Target Patients for Presentation at the ISPOR 2025 Conference (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / April 4, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions,......
31.03.25 - 18:06
 The Subscription Price for Warrants Series TO 1 in Ascelia Pharma has been Determined to SEK 2.15 and the Exercise Period is Initiated on 1 April 2025 (Accesswire)
 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE......
18.03.25 - 22:42
 Ascelia Pharma Announces Positive Outcomes of FDA Meeting and Confirms Plan to Submit the NDA for Orviglance mid-2025 (Accesswire)
 
MALMÖ, SE / ACCESS Newswire / March 18, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) , a biotech focused on improving the life of people living with rare cancer conditions, today announ......
12.02.25 - 21:54
 Nomination Committee Appointed for AGM 2025 in Ascelia Pharma AB (Accesswire)
 
MALMO, SWEDEN / ACCESS Newswire / February 12, 2025 / Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has be......
07.02.25 - 08:06
 Ascelia Pharma: Q4 and Full Year Report 2024: Completion of Full Study Report Reinforces Successful Outcomes of SPARKLE Phase 3 Study (Accesswire)
 
MALMÖ, SWEDEN / ACCESS Newswire / February 7, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Q4 and Full Year Report for 2024 (January - December), which......
30.01.25 - 14:18
 Notice of Extraordinary General Meeting in Ascelia Pharma AB (Accesswire)
 
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / Janua......
27.01.25 - 08:06
 Ascelia Pharma Announces Acceptance of Three Scientific Abstracts with SPARKLE Phase 3 Data at the European Society of Gastrointestinal and Abdominal Radiology Annual Meeting (Accesswire)
 
MALMÖ, SE / ACCESSWIRE / January 27, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, tod......
23.12.24 - 10:42
 Ascelia Pharma Patent Granted in China for Second Generation Orviglance (Accesswire)
 
MALMÖ, SWEDEN / ACCESSWIRE / December 23, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer condition......
17.12.24 - 15:43
 Ascelia Pharma Announces Acceptance of SPARKLE Phase 3 Data for Presentation at the Society of Abdominal Radiology Congress 2025 (Accesswire)
 
MALMO, SWEDEN / ACCESSWIRE / December 17, 2024 / Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific ......
29.11.24 - 12:07
 Change in Number of Shares and Votes in Ascelia Pharma AB (Accesswire)
 
MALMÖ, SE / ACCESSWIRE / November 29, 2024 / Ascelia Pharma (STO:ACE)During the month of November, the number of shares and votes in Ascelia Pharma AB have changed due to conversion of a total of 2......
22.11.24 - 21:42
 Ascelia Pharma Resolves on Conversion of Series C Shares into Ordinary Shares for Delivery to Participants in Incentive Program (Accesswire)
 
MALMÖ, SWEDEN / ACCESSWIRE / November 22, 2024 / Ascelia Pharma (STO:ACE) The board of directors of Ascelia Pharma AB ("Ascelia Pharma") has on 22 November 2024 resolved to convert 26,310 series C ......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Im Winter beim Ofen, im Sommer im Feld. - Bauernregel - Bauernweisheit
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!